HNPOLY(SZ:300630) Zheng Quan Zhi Xing·2025-05-21 13:36Core Viewpoint - Hainan Puli Pharmaceutical Co., Ltd. has received a notice regarding the termination of its stock and convertible bonds listing by the Shenzhen Stock Exchange, with trading entering a delisting arrangement starting April 28, 2025, and the last trading day set for May 21, 2025 [1][3]. Group 1: Termination of Listing - The Shenzhen Stock Exchange has decided to terminate the listing of the company's stock and convertible bonds, effective April 28, 2025, with a delisting trading period of fifteen trading days [1][3]. - The company submitted a review application for the termination decision on May 12, 2025, and received a notice of acceptance for the review application on May 21, 2025, with a review meeting scheduled for May 29, 2025 [3]. Group 2: Investor Guidance - Investors are advised that operations such as conversion, redemption, and repurchase cannot be executed during the delisting period and must be resubmitted after the bonds are listed on the delisting board [1][2]. - The company emphasizes that all relevant information should be verified through official announcements on designated information disclosure platforms [4].